Phase I study of novel antibody-drug conjugate ADCT-402
News
Since the end of March 2017, 7 patients have been recruited into the Phase I study sponsored by ADC Therapeutics (Lausanne, Switzerland) of a novel antibody drug conjugate ADCT-402 in patients with relapsed/refractory non-Hodgkin lymphoma.
TORCMEK update
News
Hear about the challenges and successes of the ongoing TORCMEK trial from Professors Peter Schmid and Gary Middleton from the study team
New recruits Eleanor Foot and Alex Briggs
News
We caught up with the Programme Office’s newest recruits: Project Officer Eleanor Foot and Student Combinations Alliance Assistant Alex Briggs.
We catch up with Sheona Scales, our new Paediatric Network Manager
News
We welcome Sheona Scales to the ECMC Programme Office and find out a bit more about her and her new role as Paediatric Network Manager.
Quality Assurance and Translational Science Group: Call for committee members and other exciting opportunities
News
Do you have an interest and passion in translational science applied within ECMC network cancer clinical trials? If so, the Quality Assurance and Translational Science Group (QATS) Network group needs you.
September Research Nurse Steering Committee Meeting
News
The ECMC Research Nurse Steering Committee met in September to discuss the group's activities for the coming year.
Get involved in the open Expression of Interest (EOI) call for researchers from the early phase (ECMC) and late phase (NIHR) cancer networks
News
The ECMC Combinations Alliance and the NIHR CRN Industry Alliance are collaborating to support access to multiple molecules from several of our partners. We invite researchers, from both the ECMC and NIHR networks, to submit novel proposals involving one or more of the novel agents tabled below in combination with standard of care chemotherapy, and/or radiotherapy, and/or another novel drug.
Site Initiation Visit (SIV) Guidance
Resource
Research nurses on the ECMC Research Nurse Network Group Steering Committee recognised a need to improve the quality of site initiation visits from sponsors. A working group made up of research nurses and academic sponsor representatives (CTUs and CRUK’s Centre for Drug Development) worked together to produce some guidance in...
Hospital and Industry Collaboration Delivers New Cancer Trial in Cardiff
News
The Cardiff ECMC has helped in bringing together expertise from two Welsh hospitals to deliver a new cancer treatment as part of a clinical trial. For the first time, the Clinical Research Facility (CRF) at the University Hospital of Wales (UHW), Velindre Cancer Centre’s Clinical Trials Unit (CTU) and TC BioPharm Ltd. have joined forces to deliver a study looking into an immunotherapy treatment in patients with advanced cancers.
Q&A with Professor Charlie Swanton
News
We caught up with the new Chief Clinician of Cancer Research UK, Professor Charlie Swanton about the future of clinical research and more.